{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T23:40:49Z","timestamp":1793317249951,"version":"4.5.0"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,7,21]],"date-time":"2021-07-21T00:00:00Z","timestamp":1626825600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,7,21]],"date-time":"2021-07-21T00:00:00Z","timestamp":1626825600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100004663","name":"Ministry of Science and Technology, Taiwan","doi-asserted-by":"publisher","award":["MOST 107-2320-B-037-024 -MY3, MOST107-2320-B-037-028-MY2 and MOST106-2311-B-037-001-MY2, 109-2320-B-037 -010 -MY3, 109-2627-M-037 -001"],"award-info":[{"award-number":["MOST 107-2320-B-037-024 -MY3, MOST107-2320-B-037-028-MY2 and MOST106-2311-B-037-001-MY2, 109-2320-B-037 -010 -MY3, 109-2627-M-037 -001"]}],"id":[{"id":"10.13039\/501100004663","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004663","name":"Ministry of Science and Technology, Taiwan","doi-asserted-by":"publisher","award":["MOST 107-2320-B-037-024 -MY3, MOST107-2320-B-037-028-MY2 and MOST106-2311-B-037-001-MY2, 109-2320-B-037 -010 -MY3, 109-2627-M-037 -001"],"award-info":[{"award-number":["MOST 107-2320-B-037-024 -MY3, MOST107-2320-B-037-028-MY2 and MOST106-2311-B-037-001-MY2, 109-2320-B-037 -010 -MY3, 109-2627-M-037 -001"]}],"id":[{"id":"10.13039\/501100004663","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004663","name":"Ministry of Science and Technology, Taiwan","doi-asserted-by":"publisher","award":["MOST 107-2320-B-037-024 -MY3, MOST107-2320-B-037-028-MY2 and MOST106-2311-B-037-001-MY2, 109-2320-B-037 -010 -MY3, 109-2627-M-037 -001"],"award-info":[{"award-number":["MOST 107-2320-B-037-024 -MY3, MOST107-2320-B-037-028-MY2 and MOST106-2311-B-037-001-MY2, 109-2320-B-037 -010 -MY3, 109-2627-M-037 -001"]}],"id":[{"id":"10.13039\/501100004663","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004663","name":"Ministry of Science and Technology, Taiwan","doi-asserted-by":"publisher","award":["MOST 107-2320-B-037-024 -MY3, MOST107-2320-B-037-028-MY2 and MOST106-2311-B-037-001-MY2, 109-2320-B-037 -010 -MY3, 109-2627-M-037 -001"],"award-info":[{"award-number":["MOST 107-2320-B-037-024 -MY3, MOST107-2320-B-037-028-MY2 and MOST106-2311-B-037-001-MY2, 109-2320-B-037 -010 -MY3, 109-2627-M-037 -001"]}],"id":[{"id":"10.13039\/501100004663","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004663","name":"Ministry of Science and Technology, Taiwan","doi-asserted-by":"publisher","award":["MOST 107-2320-B-037-024 -MY3, MOST107-2320-B-037-028-MY2 and MOST106-2311-B-037-001-MY2, 109-2320-B-037 -010 -MY3, 109-2627-M-037 -001"],"award-info":[{"award-number":["MOST 107-2320-B-037-024 -MY3, MOST107-2320-B-037-028-MY2 and MOST106-2311-B-037-001-MY2, 109-2320-B-037 -010 -MY3, 109-2627-M-037 -001"]}],"id":[{"id":"10.13039\/501100004663","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004663","name":"Ministry of Science and Technology, Taiwan","doi-asserted-by":"publisher","award":["MOST 107-2320-B-037-024 -MY3, MOST107-2320-B-037-028-MY2 and MOST106-2311-B-037-001-MY2, 109-2320-B-037 -010 -MY3, 109-2627-M-037 -001"],"award-info":[{"award-number":["MOST 107-2320-B-037-024 -MY3, MOST107-2320-B-037-028-MY2 and MOST106-2311-B-037-001-MY2, 109-2320-B-037 -010 -MY3, 109-2627-M-037 -001"]}],"id":[{"id":"10.13039\/501100004663","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004663","name":"Ministry of Science and Technology, Taiwan","doi-asserted-by":"publisher","award":["MOST 107-2320-B-037-024 -MY3, MOST107-2320-B-037-028-MY2 and MOST106-2311-B-037-001-MY2, 109-2320-B-037 -010 -MY3, 109-2627-M-037 -001"],"award-info":[{"award-number":["MOST 107-2320-B-037-024 -MY3, MOST107-2320-B-037-028-MY2 and MOST106-2311-B-037-001-MY2, 109-2320-B-037 -010 -MY3, 109-2627-M-037 -001"]}],"id":[{"id":"10.13039\/501100004663","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004663","name":"Ministry of Science and Technology, Taiwan","doi-asserted-by":"publisher","award":["MOST 107-2320-B-037-024 -MY3, MOST107-2320-B-037-028-MY2 and MOST106-2311-B-037-001-MY2, 109-2320-B-037 -010 -MY3, 109-2627-M-037 -001"],"award-info":[{"award-number":["MOST 107-2320-B-037-024 -MY3, MOST107-2320-B-037-028-MY2 and MOST106-2311-B-037-001-MY2, 109-2320-B-037 -010 -MY3, 109-2627-M-037 -001"]}],"id":[{"id":"10.13039\/501100004663","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004663","name":"Ministry of Science and Technology, Taiwan","doi-asserted-by":"publisher","award":["MOST 107-2320-B-037-024 -MY3, MOST107-2320-B-037-028-MY2 and MOST106-2311-B-037-001-MY2, 109-2320-B-037 -010 -MY3, 109-2627-M-037 -001"],"award-info":[{"award-number":["MOST 107-2320-B-037-024 -MY3, MOST107-2320-B-037-028-MY2 and MOST106-2311-B-037-001-MY2, 109-2320-B-037 -010 -MY3, 109-2627-M-037 -001"]}],"id":[{"id":"10.13039\/501100004663","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004663","name":"Ministry of Science and Technology, Taiwan","doi-asserted-by":"publisher","award":["MOST 107-2320-B-037-024 -MY3, MOST107-2320-B-037-028-MY2 and MOST106-2311-B-037-001-MY2, 109-2320-B-037 -010 -MY3, 109-2627-M-037 -001"],"award-info":[{"award-number":["MOST 107-2320-B-037-024 -MY3, MOST107-2320-B-037-028-MY2 and MOST106-2311-B-037-001-MY2, 109-2320-B-037 -010 -MY3, 109-2627-M-037 -001"]}],"id":[{"id":"10.13039\/501100004663","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004663","name":"Ministry of Science and Technology, Taiwan","doi-asserted-by":"publisher","award":["MOST 107-2320-B-037-024 -MY3, MOST107-2320-B-037-028-MY2 and MOST106-2311-B-037-001-MY2, 109-2320-B-037 -010 -MY3, 109-2627-M-037 -001"],"award-info":[{"award-number":["MOST 107-2320-B-037-024 -MY3, MOST107-2320-B-037-028-MY2 and MOST106-2311-B-037-001-MY2, 109-2320-B-037 -010 -MY3, 109-2627-M-037 -001"]}],"id":[{"id":"10.13039\/501100004663","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004663","name":"Ministry of Science and Technology, Taiwan","doi-asserted-by":"publisher","award":["MOST 107-2320-B-037-024 -MY3, MOST107-2320-B-037-028-MY2 and MOST106-2311-B-037-001-MY2, 109-2320-B-037 -010 -MY3, 109-2627-M-037 -001"],"award-info":[{"award-number":["MOST 107-2320-B-037-024 -MY3, MOST107-2320-B-037-028-MY2 and MOST106-2311-B-037-001-MY2, 109-2320-B-037 -010 -MY3, 109-2627-M-037 -001"]}],"id":[{"id":"10.13039\/501100004663","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004663","name":"Ministry of Science and Technology, Taiwan","doi-asserted-by":"publisher","award":["MOST 107-2320-B-037-024 -MY3, MOST107-2320-B-037-028-MY2 and MOST106-2311-B-037-001-MY2, 109-2320-B-037 -010 -MY3, 109-2627-M-037 -001"],"award-info":[{"award-number":["MOST 107-2320-B-037-024 -MY3, MOST107-2320-B-037-028-MY2 and MOST106-2311-B-037-001-MY2, 109-2320-B-037 -010 -MY3, 109-2627-M-037 -001"]}],"id":[{"id":"10.13039\/501100004663","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004694","name":"Kaohsiung Medical University, Taiwan","doi-asserted-by":"crossref","award":["KMU-DK108002, KMU-DK109001, KMU-Q108001, KMU-Q109002, KMU-DK109004, KMU-KI110004, 108-CCH-KMU-010, NK-108I08"],"award-info":[{"award-number":["KMU-DK108002, KMU-DK109001, KMU-Q108001, KMU-Q109002, KMU-DK109004, KMU-KI110004, 108-CCH-KMU-010, NK-108I08"]}],"id":[{"id":"10.13039\/501100004694","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100004694","name":"Kaohsiung Medical University, Taiwan","doi-asserted-by":"crossref","award":["KMU-DK108002, KMU-DK109001, KMU-Q108001, KMU-Q109002, KMU-DK109004, KMU-KI110004, 108-CCH-KMU-010, NK-108I08"],"award-info":[{"award-number":["KMU-DK108002, KMU-DK109001, KMU-Q108001, KMU-Q109002, KMU-DK109004, KMU-KI110004, 108-CCH-KMU-010, NK-108I08"]}],"id":[{"id":"10.13039\/501100004694","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100015045","name":"Kaohsiung Armed Forces General Hospital","doi-asserted-by":"publisher","award":["802KB109388"],"award-info":[{"award-number":["802KB109388"]}],"id":[{"id":"10.13039\/501100015045","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004737","name":"National Health Research Institutes, Taiwan","doi-asserted-by":"crossref","award":["NHRI-EX107-10729EI and NHRI-EX108-10729EI"],"award-info":[{"award-number":["NHRI-EX107-10729EI and NHRI-EX108-10729EI"]}],"id":[{"id":"10.13039\/501100004737","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Academia Sinica, Taiwan","award":["AS-107-TP-B11 and AS-TP-107-L11"],"award-info":[{"award-number":["AS-107-TP-B11 and AS-TP-107-L11"]}]},{"name":"Ministry of Education, Taiwan","award":["108RSB0029"],"award-info":[{"award-number":["108RSB0029"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Canakinumab is a fully human monoclonal antibody that specifically neutralizes human interleukin (IL)-1\u03b2 and has been approved by the US Food and Drug Administration for treating different types of autoinflammatory disorders such as cryopyrin-associated periodic syndrome, tumor necrosis factor receptor-associated periodic syndrome and systemic juvenile idiopathic arthritis. However, long-term systemic neutralization of IL-1\u03b2 by Canakinumab may cause severe adverse events such as serious upper respiratory tract infections and inflammation, thereby decreasing the quality of life of patients. Here, we used an IgG1 hinge as an Ab lock to cover the IL-1\u03b2-binding site of Canakinumab by linking with matrix metalloprotease 9 (MMP-9) substrate to generate pro-Canakinumab that can be specifically activated in the inflamed regions in autoinflammatory diseases to enhance the selectivity and safety of treatment. The Ab lock significantly inhibited the IL-1\u03b2-binding by 68-fold compared with Canakinumab, and MMP-9 completely restored the IL-1\u03b2 neutralizing ability of pro-Canakinumab within 60\u00a0min and blocked IL-1\u03b2-downstream signaling and IL-1\u03b2-regulated genes (i.e., IL-6). It is expected that MMP-9 cleavable and efficient Ab lock will be able to significantly enhance the selective reaction of Canakinumab at the disease site and reduce the on-target toxicities of Canakinumab during systemic circulation, thereby showing potential for development to improve the safety and quality of life of patients with autoinflammatory disorders in the future.<\/jats:p>","DOI":"10.1038\/s41598-021-94298-y","type":"journal-article","created":{"date-parts":[[2021,7,21]],"date-time":"2021-07-21T10:07:53Z","timestamp":1626862073000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Selective activation of pro-anti-IL-1\u03b2 antibody enhances specificity for autoinflammatory disorder therapy"],"prefix":"10.1038","volume":"11","author":[{"given":"Wen-Wei","family":"Lin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yun-Chi","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo-Cheng","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chih-Hung","family":"Chuang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi-An","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I.-Ju","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui-Ju","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kai-Wen","family":"Ho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tzu-Yi","family":"Liao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"En-Shuo","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ting-Yi","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Long-Sen","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shih-Ting","family":"Hong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tian-Lu","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,7,21]]},"reference":[{"issue":"6","key":"94298_CR1","doi-asserted-by":"publisher","first-page":"2095","DOI":"10.1182\/blood.V87.6.2095.bloodjournal8762095","volume":"87","author":"CA Dinarello","year":"1996","unstructured":"Dinarello, C. A. Biologic basis for interleukin-1 in disease. Blood 87(6), 2095\u20132147 (1996).","journal-title":"Blood"},{"issue":"1","key":"94298_CR2","doi-asserted-by":"publisher","first-page":"3","DOI":"10.4161\/mabs.2.1.10328","volume":"2","author":"E Dhimolea","year":"2010","unstructured":"Dhimolea, E. Canakinumab. MAbs 2(1), 3\u201313. https:\/\/doi.org\/10.4161\/mabs.2.1.10328 (2010).","journal-title":"MAbs"},{"issue":"20","key":"94298_CR3","doi-asserted-by":"publisher","first-page":"1908","DOI":"10.1056\/NEJMoa1706314","volume":"378","author":"F De Benedetti","year":"2018","unstructured":"De Benedetti, F. et al. Canakinumab for the treatment of autoinflammatory recurrent fever syndromes. N Engl J Med. 378(20), 1908\u20131919. https:\/\/doi.org\/10.1056\/NEJMoa1706314 (2018).","journal-title":"N Engl J Med."},{"issue":"6","key":"94298_CR4","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1080\/03009742.2017.1288827","volume":"46","author":"G Horneff","year":"2017","unstructured":"Horneff, G., Peitz, J., Kekow, J. & Foell, D. Canakinumab for first line steroid-free treatment in a child with systemic-onset juvenile idiopathic arthritis. Scand J Rheumatol 46(6), 500\u2013501. https:\/\/doi.org\/10.1080\/03009742.2017.1288827 (2017).","journal-title":"Scand J Rheumatol"},{"issue":"4","key":"94298_CR5","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1165\/rcmb.2004-0309OC","volume":"32","author":"U Lappalainen","year":"2005","unstructured":"Lappalainen, U., Whitsett, J. A., Wert, S. E., Tichelaar, J. W. & Bry, K. Interleukin-1beta causes pulmonary inflammation, emphysema, and airway remodeling in the adult murine lung. Am J Respir Cell Mol Biol 32(4), 311\u2013318. https:\/\/doi.org\/10.1165\/rcmb.2004-0309OC (2005).","journal-title":"Am J Respir Cell Mol Biol"},{"issue":"12","key":"94298_CR6","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0028457","volume":"6","author":"FM Botelho","year":"2011","unstructured":"Botelho, F. M. et al. IL-1alpha\/IL-1R1 expression in chronic obstructive pulmonary disease and mechanistic relevance to smoke-induced neutrophilia in mice. PLoS ONE 6(12), e28457. https:\/\/doi.org\/10.1371\/journal.pone.0028457 (2011).","journal-title":"PLoS ONE"},{"key":"94298_CR7","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.pupt.2015.01.005","volume":"31","author":"P Rogliani","year":"2015","unstructured":"Rogliani, P., Calzetta, L., Ora, J. & Matera, M. G. Canakinumab for the treatment of chronic obstructive pulmonary disease. Pulm Pharmacol Ther 31, 15\u201327. https:\/\/doi.org\/10.1016\/j.pupt.2015.01.005 (2015).","journal-title":"Pulm Pharmacol Ther"},{"key":"94298_CR8","unstructured":"ILARIS\u00ae (canakinumab) for injection, f. s. u. I. U. S. A."},{"issue":"5","key":"94298_CR9","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1084\/jem.20082481","volume":"206","author":"HJ Lachmann","year":"2009","unstructured":"Lachmann, H. J. et al. In vivo regulation of interleukin 1beta in patients with cryopyrin-associated periodic syndromes. J Exp Med 206(5), 1029\u20131036. https:\/\/doi.org\/10.1084\/jem.20082481 (2009).","journal-title":"J Exp Med"},{"issue":"4","key":"94298_CR10","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1016\/j.ahj.2011.06.012","volume":"162","author":"PM Ridker","year":"2011","unstructured":"Ridker, P. M., Thuren, T., Zalewski, A. & Libby, P. Interleukin-1beta inhibition and the prevention of recurrent cardiovascular events: rationale and design of the Canakinumab Anti-inflammatory Thrombosis Outcomes Study (CANTOS). Am Heart J 162(4), 597\u2013605. https:\/\/doi.org\/10.1016\/j.ahj.2011.06.012 (2011).","journal-title":"Am Heart J"},{"issue":"1","key":"94298_CR11","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1186\/s12929-020-00652-z","volume":"27","author":"WW Lin","year":"2020","unstructured":"Lin, W. W., Lu, Y. C., Chuang, C. H. & Cheng, T. L. Ab locks for improving the selectivity and safety of antibody drugs. J Biomed Sci 27(1), 76. https:\/\/doi.org\/10.1186\/s12929-020-00652-z (2020).","journal-title":"J Biomed Sci"},{"key":"94298_CR12","doi-asserted-by":"publisher","first-page":"507","DOI":"10.3389\/fcimb.2017.00507","volume":"7","author":"JL Johnson","year":"2017","unstructured":"Johnson, J. L. et al. Increased neutrophil secretion induced by NLRP3 mutation links the inflammasome to azurophilic granule exocytosis. Front Cell Infect Microbiol 7, 507. https:\/\/doi.org\/10.3389\/fcimb.2017.00507 (2017).","journal-title":"Front Cell Infect Microbiol"},{"issue":"1\u20132","key":"94298_CR13","doi-asserted-by":"publisher","first-page":"21","DOI":"10.3109\/15419061.2013.775257","volume":"20","author":"G Caramori","year":"2013","unstructured":"Caramori, G., Casolari, P. & Adcock, I. Role of transcription factors in the pathogenesis of asthma and COPD. Cell Commun Adhes 20(1\u20132), 21\u201340. https:\/\/doi.org\/10.3109\/15419061.2013.775257 (2013).","journal-title":"Cell Commun Adhes"},{"issue":"1\u20133","key":"94298_CR14","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1016\/j.ejphar.2004.07.047","volume":"498","author":"P Castro","year":"2004","unstructured":"Castro, P. et al. Inhibition of interleukin-1beta reduces mouse lung inflammation induced by exposure to cigarette smoke. Eur J Pharmacol 498(1\u20133), 279\u2013286. https:\/\/doi.org\/10.1016\/j.ejphar.2004.07.047 (2004).","journal-title":"Eur J Pharmacol"},{"issue":"5","key":"94298_CR15","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1165\/ajrcmb.26.5.4685","volume":"26","author":"RE Russell","year":"2002","unstructured":"Russell, R. E. et al. Release and activity of matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 by alveolar macrophages from patients with chronic obstructive pulmonary disease. Am J Respir Cell Mol Biol 26(5), 602\u2013609. https:\/\/doi.org\/10.1165\/ajrcmb.26.5.4685 (2002).","journal-title":"Am J Respir Cell Mol Biol"},{"key":"94298_CR16","doi-asserted-by":"publisher","first-page":"18","DOI":"10.7150\/thno\/v01p0018","volume":"1","author":"L Zhu","year":"2011","unstructured":"Zhu, L. et al. Real-time video imaging of protease expression in vivo. Theranostics 1, 18\u201327. https:\/\/doi.org\/10.7150\/thno\/v01p0018 (2011).","journal-title":"Theranostics"},{"key":"94298_CR17","doi-asserted-by":"publisher","first-page":"490","DOI":"10.3389\/fphar.2016.00490","volume":"7","author":"WC Chen","year":"2016","unstructured":"Chen, W. C., Tseng, C. K., Chen, B. H., Lin, C. K. & Lee, J. C. Grape seed extract attenuates hepatitis C virus replication and virus-induced inflammation. Front Pharmacol 7, 490. https:\/\/doi.org\/10.3389\/fphar.2016.00490 (2016).","journal-title":"Front Pharmacol"},{"issue":"12","key":"94298_CR18","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1016\/0968-0004(90)90302-r","volume":"15","author":"RJ Jackson","year":"1990","unstructured":"Jackson, R. J., Howell, M. T. & Kaminski, A. The novel mechanism of initiation of picornavirus RNA translation. Trends Biochem Sci 15(12), 477\u2013483. https:\/\/doi.org\/10.1016\/0968-0004(90)90302-r (1990).","journal-title":"Trends Biochem Sci"},{"issue":"8","key":"94298_CR19","doi-asserted-by":"publisher","first-page":"2636","DOI":"10.1128\/JVI.62.8.2636-2643.1988","volume":"62","author":"SK Jang","year":"1988","unstructured":"Jang, S. K. et al. A segment of the 5\u2019 nontranslated region of encephalomyocarditis virus RNA directs internal entry of ribosomes during in vitro translation. J Virol 62(8), 2636\u20132643. https:\/\/doi.org\/10.1128\/JVI.62.8.2636-2643.1988 (1988).","journal-title":"J Virol"},{"issue":"4","key":"94298_CR20","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1007\/s00296-010-1592-1","volume":"31","author":"KS Kim","year":"2011","unstructured":"Kim, K. S. et al. Expression levels and association of gelatinases MMP-2 and MMP-9 and collagenases MMP-1 and MMP-13 with VEGF in synovial fluid of patients with arthritis. Rheumatol Int 31(4), 543\u2013547. https:\/\/doi.org\/10.1007\/s00296-010-1592-1 (2011).","journal-title":"Rheumatol Int"},{"issue":"1","key":"94298_CR21","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/j.yexcr.2014.08.040","volume":"331","author":"X Liu","year":"2015","unstructured":"Liu, X. et al. IL-1beta induces IL-6 production in retinal Muller cells predominantly through the activation of p38 MAPK\/NF-kappaB signaling pathway. Exp Cell Res 331(1), 223\u2013231. https:\/\/doi.org\/10.1016\/j.yexcr.2014.08.040 (2015).","journal-title":"Exp Cell Res"},{"key":"94298_CR22","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.3006682","author":"LR Desnoyers","year":"2013","unstructured":"Desnoyers, L. R. et al. Tumor-specific activation of an EGFR-targeting probody enhances therapeutic index. Sci Transl Med https:\/\/doi.org\/10.1126\/scitranslmed.3006682 (2013).","journal-title":"Sci Transl Med"},{"issue":"3","key":"94298_CR23","doi-asserted-by":"publisher","first-page":"804","DOI":"10.1016\/j.jconrel.2012.05.035","volume":"161","author":"O Erster","year":"2012","unstructured":"Erster, O. et al. Site-specific targeting of antibody activity in vivo mediated by disease-associated proteases. J Control Rel 161(3), 804\u2013812. https:\/\/doi.org\/10.1016\/j.jconrel.2012.05.035 (2012).","journal-title":"J Control Rel"},{"issue":"2","key":"94298_CR24","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1080\/19420862.2015.1008352","volume":"7","author":"Y Yang","year":"2015","unstructured":"Yang, Y. et al. Generation and characterization of a target-selectively activated antibody against epidermal growth factor receptor with enhanced anti-tumor potency. MAbs 7(2), 440\u2013450. https:\/\/doi.org\/10.1080\/19420862.2015.1008352 (2015).","journal-title":"MAbs"},{"issue":"6","key":"94298_CR25","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pbio.3000286","volume":"17","author":"YC Lu","year":"2019","unstructured":"Lu, Y. C. et al. Specific activation of pro-Infliximab enhances selectivity and safety of rheumatoid arthritis therapy. PLoS Biol 17(6), e3000286. https:\/\/doi.org\/10.1371\/journal.pbio.3000286 (2019).","journal-title":"PLoS Biol"},{"issue":"2","key":"94298_CR26","doi-asserted-by":"publisher","DOI":"10.1002\/pri.1766","volume":"24","author":"RMP Souza","year":"2019","unstructured":"Souza, R. M. P. et al. Inspiratory muscle strength, diaphragmatic mobility, and body composition in chronic obstructive pulmonary disease. Physiother Res Int 24(2), e1766. https:\/\/doi.org\/10.1002\/pri.1766 (2019).","journal-title":"Physiother Res Int"},{"issue":"2","key":"94298_CR27","doi-asserted-by":"publisher","first-page":"269","DOI":"10.20471\/acc.2017.56.02.10","volume":"56","author":"J Ostojic","year":"2017","unstructured":"Ostojic, J. & Pintaric, H. Chronic obstructive pulmonary disease and heart failure: closer than close. Acta Clin Croat 56(2), 269\u2013276. https:\/\/doi.org\/10.20471\/acc.2017.56.02.10 (2017).","journal-title":"Acta Clin Croat"},{"key":"94298_CR28","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1016\/j.scitotenv.2019.04.358","volume":"677","author":"SC Ho","year":"2019","unstructured":"Ho, S. C. et al. Chronic obstructive pulmonary disease patients have a higher risk of occurrence of pneumonia by air pollution. Sci Total Environ 677, 524\u2013529. https:\/\/doi.org\/10.1016\/j.scitotenv.2019.04.358 (2019).","journal-title":"Sci Total Environ"},{"issue":"1","key":"94298_CR29","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1186\/s13023-018-0799-1","volume":"13","author":"CM Mulders-Manders","year":"2018","unstructured":"Mulders-Manders, C. M. et al. Decreased quality of life and societal impact of cryopyrin-associated periodic syndrome treated with canakinumab: A questionnaire based cohort study. Orphanet J Rare Dis 13(1), 59. https:\/\/doi.org\/10.1186\/s13023-018-0799-1 (2018).","journal-title":"Orphanet J Rare Dis"},{"issue":"1","key":"94298_CR30","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1007\/s10792-017-0785-y","volume":"39","author":"L Cocho","year":"2019","unstructured":"Cocho, L., Urbaneja, E. & Herreras, J. M. Vision-threatening bilateral panuveitis and TRAPS in a child: An uncommon association. Int Ophthalmol 39(1), 219\u2013223. https:\/\/doi.org\/10.1007\/s10792-017-0785-y (2019).","journal-title":"Int Ophthalmol"},{"issue":"25","key":"94298_CR31","doi-asserted-by":"publisher","first-page":"2385","DOI":"10.1056\/NEJMoa1112802","volume":"367","author":"F De Benedetti","year":"2012","unstructured":"De Benedetti, F. et al. Randomized trial of tocilizumab in systemic juvenile idiopathic arthritis. N Engl J Med 367(25), 2385\u201395. https:\/\/doi.org\/10.1056\/NEJMoa1112802 (2012).","journal-title":"N Engl J Med"},{"key":"94298_CR32","doi-asserted-by":"publisher","first-page":"2141","DOI":"10.2147\/COPD.S121416","volume":"12","author":"SP Lakshmi","year":"2017","unstructured":"Lakshmi, S. P., Reddy, A. T. & Reddy, R. C. Emerging pharmaceutical therapies for COPD. Int J Chron Obstruct Pulmon Dis 12, 2141\u20132156. https:\/\/doi.org\/10.2147\/COPD.S121416 (2017).","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"key":"94298_CR33","doi-asserted-by":"publisher","first-page":"512","DOI":"10.3389\/fphar.2017.00512","volume":"8","author":"KC Pandey","year":"2017","unstructured":"Pandey, K. C., De, S. & Mishra, P. K. Role of proteases in chronic obstructive pulmonary disease. Front Pharmacol 8, 512. https:\/\/doi.org\/10.3389\/fphar.2017.00512 (2017).","journal-title":"Front Pharmacol"},{"issue":"9","key":"94298_CR34","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1164\/rccm.201509-1869OC","volume":"193","author":"S Vedel-Krogh","year":"2016","unstructured":"Vedel-Krogh, S., Nielsen, S. F., Lange, P., Vestbo, J. & Nordestgaard, B. G. Blood eosinophils and exacerbations in chronic obstructive pulmonary disease. The Copenhagen general population study. Am J Respir Crit Care Med 193(9), 965\u201374. https:\/\/doi.org\/10.1164\/rccm.201509-1869OC (2016).","journal-title":"Am J Respir Crit Care Med"},{"issue":"2","key":"94298_CR35","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1097\/ACI.0000000000000251","volume":"16","author":"G Varricchi","year":"2016","unstructured":"Varricchi, G., Bagnasco, D., Borriello, F., Heffler, E. & Canonica, G. W. Interleukin-5 pathway inhibition in the treatment of eosinophilic respiratory disorders: evidence and unmet needs. Curr Opin Allergy Clin Immunol 16(2), 186\u2013200. https:\/\/doi.org\/10.1097\/ACI.0000000000000251 (2016).","journal-title":"Curr Opin Allergy Clin Immunol"},{"issue":"2","key":"94298_CR36","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1159\/000334900","volume":"84","author":"H Grubek-Jaworska","year":"2012","unstructured":"Grubek-Jaworska, H. et al. IL-6 and IL-13 in induced sputum of COPD and asthma patients: correlation with respiratory tests. Respiration 84(2), 101\u2013107. https:\/\/doi.org\/10.1159\/000334900 (2012).","journal-title":"Respiration"},{"key":"94298_CR37","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1186\/1465-9921-8-64","volume":"8","author":"JS Lee","year":"2007","unstructured":"Lee, J. S. et al. Inverse association of plasma IL-13 and inflammatory chemokines with lung function impairment in stable COPD: a cross-sectional cohort study. Respir Res 8, 64. https:\/\/doi.org\/10.1186\/1465-9921-8-64 (2007).","journal-title":"Respir Res"},{"issue":"5","key":"94298_CR38","doi-asserted-by":"publisher","first-page":"1075","DOI":"10.1165\/rcmb.2010-0327OC","volume":"45","author":"T Tanabe","year":"2011","unstructured":"Tanabe, T. et al. Clarithromycin inhibits interleukin-13-induced goblet cell hyperplasia in human airway cells. Am J Respir Cell Mol Biol 45(5), 1075\u20131083. https:\/\/doi.org\/10.1165\/rcmb.2010-0327OC (2011).","journal-title":"Am J Respir Cell Mol Biol"},{"issue":"2","key":"94298_CR39","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1378\/chest.08-1583","volume":"135","author":"EJ Lee","year":"2009","unstructured":"Lee, E. J. et al. Proteomic analysis in lung tissue of smokers and COPD patients. Chest 135(2), 344\u2013352. https:\/\/doi.org\/10.1378\/chest.08-1583 (2009).","journal-title":"Chest"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-94298-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-94298-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-94298-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,3]],"date-time":"2022-12-03T11:28:56Z","timestamp":1670066936000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-94298-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7,21]]},"references-count":39,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,12]]}},"alternative-id":["94298"],"URL":"https:\/\/doi.org\/10.1038\/s41598-021-94298-y","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,7,21]]},"assertion":[{"value":"12 March 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 July 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 July 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"14846"}}